Home › Pharmaceuticals
Pharmaceuticals Market Research Report
The global pharmaceuticals market is experiencing constant growth due to the worldwide increase in life expectancy, as well as the increasing incidence of chronic and infectious diseases. The steadily increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the pharmaceuticals industry. Leading industry players allocate around 20% of their turnover to R&D to maintain a competitive edge. The emergence of biopharmaceuticals has opened a new arena for drug discovery; and breakthroughs in the fields of proteomics and genomics have also enabled drug manufacturers to develop more effective drugs and therapies. While the industry has begun attracting significant public funding and tax exemption, it still faces the challenges of short product lifecycles and of developing blockbuster drugs. The pharmaceuticals industry is dominated by the U.S., which holds around 45% of the global market share. However, the markets in emerging economies like in China and India are expected to show a double digit growth. This is because global pharmaceutical giants are increasingly outsourcing R&D to lower costs and to take advantage of the scientific work pool in these nations.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Global Weight Loss and Diet Management Market (2009 - 2014)Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. |
July 2009 | $ 4650 |
|
Autoimmune Treatment Market (2009 - 2014)The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market. |
September 2009 | $ 4650 |
|
Opportunity Analysis of H1N1 (swine flu) Vaccination MarketThe increase in public awareness and government initiatives, as a consequence of scare from pandemic flu has resulted in the drastic rise in demand for the Influenza Vaccines. This transient boost in demand of seasonal influenza vaccines is an impact of prevailing H1N1 pandemic, due to apprehension and lack of clarity among the general public. The emerging technologies in production are going to give a new face to the market dynamics of this market. The upcoming vaccines and drugs by various players in the market such as Novartis’ Optaflu and ProteinSciences’ FluBlock, along with the emerging technologies in production are going to give a new face to the market dynamics of this market. |
October 2009 | $ 4650 |
|
Sales Force Effectiveness (2009 - 2014)Pharmaceutical companies are aiming to increase their return on investment (ROI) from their sales representatives. Improvement in rep performance reduces ineffective sales calls, optimizes cost per detail and increases revenue per call. Companies are thus exploring all available options under their sales force effectiveness strategy. |
December 2009 | $ 4650 | |
Diabetes Market (Devices and Drugs)Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share |
December 2009 | $ 4650 | |
HIV/AIDS - Therapies and Global Market (2009 - 2014)HIV/AIDS diagnosis and therapy is one of the most complex healthcare problem faced by the medical sector. This report keeps track of the latest diagnostics technologies developed and provides a comprehensive coverage of HIV tests and treatments with a special emphasis on the most affected regions of Africa and Asia. It also outlines the market potential and size of HIV tests, treatments and diagnostics. |
December 2009 | $ 4650 | |
Global Oncology Pharmaceuticals & Therapeutics MarketEach section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
December 2009 | $ 4650 |
|
US Preterm Infant Care Market (2009-2014)Preterm infant care forms a significant part of the pediatric healthcare market in U.S as preterm births are on a alarming rise in the nation. Preterm births are one of the leading causes of infant mortality in U.S with 1 in 8 births being preterm. Induced fertility and labor treatments, poor prenatal care, inappropriate maternal age, obesity, smoking are some of the major reasons responsible for increasing incidence of preterm births in the country. Preterm infant care products such as infant care devices, infant formula and drugs face a great demand in United States due to the absolute necessity of such products in sustaining baby lives. The products are indispensable in saving preterm babies because they are biologically immature and require external medical assistance in the form of respiratory, nutritional and thermal control support for survival. Infant care products have helped to increase the survival of preterm babies in the country. The criticality of the products in preterm infant care is driving the market. Furthermore, technology advances in regards to multi function equipments are also propelling the growth of the market. |
January 2010 | $ 4650 |
|
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Search reports
Pharmaceuticals ›
Energy and Power Supplies ›
Biotech ›
Food and Beverages ›
Chemicals ›
Medical Devices ›
Advanced Materials ›
Semiconductor and Electronics ›
Industrial Automation ›
Telecom and IT ›
Consumer Goods ›
Automotive and Transportation ›
Banking & Financial Services ›
Free Report Updates
